• |
  • |
  • |
  • |
Donate

Product

Hydroxycarbamide in very young children with sickle cell anemia: A multicentre, randomised, controlled trial (BABY HUG).

Center:
Fiscal Year:
2011
Contact Information:
Product Description:
Outcome of randomized clinical trial of hydroxyurea in infants and toddlers with sickle cell anemia. Outcomes included pain, hospitalizations,and neurocognitive function.
Keyword(s):
sickle cell anemia, hydroxyurea, infants, neurodevelopment
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A